Maternal Serology and Cord Blood Platelet Counts in 46 HPA-1a Alloimmunized Women
Unique Study Number . | Parity-150 . | Earliest Antibody Positive Sample . | Anti–HPA-1a Titer in Third Trimester . | HPA-1 Genotype/ Phenotype of Father . | Platelet Count at Birth (×109/L) . |
---|---|---|---|---|---|
Persistent Antenatal Antibodies With Severe Thrombocytopenia (n = 10) | |||||
274 | 4 + 0 | 7 | 32 | 1a1b | 37 |
57 | 0 + 1 | 8 | 128 | 1a1b | 6 |
622 | 1 + 0 | 10 | 64 | ND | 9 |
306-151 | 2 + 1 | 16 | 128 | ND | 17 |
479 | 2 + 0 | 17 | 64 | 1a1a | 8 |
152-152 | 0 + 1 | 16 | 64 | ND | |
0 + 2 | 21 | 16 | 1a1b | 5 | |
347-153 | 0 + 0 | 26 | 64 | 1a1a | 4 |
421 | 0 + 0 | 32 | 8 | 1a1a | 2 |
LR-155 | 0 + 0 | ND | ND | 1a1a | 14 |
SL-155 | 0 + 0 | ND | ND | 1a1a | ND |
Persistent Antenatal Antibodies With Mild Thrombocytopenia (n = 10) | |||||
223 | 3 + 0 | 9 | 16 | 1a1b | 110 |
598 | 0 + 1 | 12 | 8 | ND | 60 |
639 | 1 + 0 | 12 | 2 | 1a1b | 107 |
60 | 1 + 4 | 14 | 1 | 1a1a | 117 |
424 | 1 + 0 | 17 | 1 | 1a1a | 52 |
620 | 0 + 0 | 17 | 2 | 1a1a | 132 |
64 | 1 + 0 | 19 | 4 | 1a1a | 94 |
330 | 2 + 0 | 21 | 32 | 1a1a | 97 |
54 | 0 + 0 | 26 | 1 | ND | 118 |
178 | 0 + 0 | 30 | 1 | ND | 140 |
Persistent Antenatal Antibodies With Normal Platelet Counts (n = 7) | |||||
599 | 1 + 2 | 11 | 1 | 1a1a | 335 |
248 | 1 + 0 | 16 | 1 | 1a pos | 215 |
322 | 1 + 0 | 16 | 32 | 1a1a | 197 |
571 | 0 + 0 | 17 | 8 | 1a1a | 323 |
481 | 2 + 1 | 18 | 16 | 1a1b | 192 |
431 | 0 + 0 | 37 | 2 | 1a1b | 491 |
607 | 0 + 0 | 37 | 4 | ND | 228 |
Transient Antenatal Antibodies (n = 6) | |||||
487 | 3 + 1 | 8 | 2 | 1a1b | ND |
614 | 1 + 0 | 8 | 2 | 1a1b | 267 |
605 | 1 + 0 | 9 | 1 | ND | 133 |
398 | 3 + 0 | 15 | 1 | ND | 261 |
206 | 2 + 1 | 16 | 1 | ND | 604 |
420 | 0 + 1 | 20 | 1 | ND | 352 |
Postnatal Antibodies Only With HPA-1a–Positive Baby¶ (n = 7) | |||||
42-151 | 0 + 0 | PN | 1 | 1a1a | ND |
62 | 2 + 1 | PN | 8 | ND | 275 |
221 | 0 + 1 | PN | 2 | 1a1a | 153 |
267 | 1 + 0 | PN | 4 | 1a1b | 274 |
302 | 1 + 3 | PN | 4 | 1a1a | SA 15/40 |
325 | 0 + 0 | PN | 1 | ND | 146 |
412 | 1 + 2 | PN | 4 | 1a1a | 53 |
Antenatal Antibodies With HPA-1a–Negative Baby (n = 6) | |||||
417 | 1 + 1 | 11 | 32 | 1a1b | 286 |
199# | 0 + 1 | 17 | 4 | 1a1b | 222 |
230-160 | 1 + 2 | 17 | 16 | 1b1b | 229 |
304 | 4 + 0 | 26 | 2 | 1a1b | 384 |
172 | 2 + 0 | 29 | 1 | 1a1b | 341 |
542 | 0 + 1 | 35 | 2 | ND | 285 |
Unique Study Number . | Parity-150 . | Earliest Antibody Positive Sample . | Anti–HPA-1a Titer in Third Trimester . | HPA-1 Genotype/ Phenotype of Father . | Platelet Count at Birth (×109/L) . |
---|---|---|---|---|---|
Persistent Antenatal Antibodies With Severe Thrombocytopenia (n = 10) | |||||
274 | 4 + 0 | 7 | 32 | 1a1b | 37 |
57 | 0 + 1 | 8 | 128 | 1a1b | 6 |
622 | 1 + 0 | 10 | 64 | ND | 9 |
306-151 | 2 + 1 | 16 | 128 | ND | 17 |
479 | 2 + 0 | 17 | 64 | 1a1a | 8 |
152-152 | 0 + 1 | 16 | 64 | ND | |
0 + 2 | 21 | 16 | 1a1b | 5 | |
347-153 | 0 + 0 | 26 | 64 | 1a1a | 4 |
421 | 0 + 0 | 32 | 8 | 1a1a | 2 |
LR-155 | 0 + 0 | ND | ND | 1a1a | 14 |
SL-155 | 0 + 0 | ND | ND | 1a1a | ND |
Persistent Antenatal Antibodies With Mild Thrombocytopenia (n = 10) | |||||
223 | 3 + 0 | 9 | 16 | 1a1b | 110 |
598 | 0 + 1 | 12 | 8 | ND | 60 |
639 | 1 + 0 | 12 | 2 | 1a1b | 107 |
60 | 1 + 4 | 14 | 1 | 1a1a | 117 |
424 | 1 + 0 | 17 | 1 | 1a1a | 52 |
620 | 0 + 0 | 17 | 2 | 1a1a | 132 |
64 | 1 + 0 | 19 | 4 | 1a1a | 94 |
330 | 2 + 0 | 21 | 32 | 1a1a | 97 |
54 | 0 + 0 | 26 | 1 | ND | 118 |
178 | 0 + 0 | 30 | 1 | ND | 140 |
Persistent Antenatal Antibodies With Normal Platelet Counts (n = 7) | |||||
599 | 1 + 2 | 11 | 1 | 1a1a | 335 |
248 | 1 + 0 | 16 | 1 | 1a pos | 215 |
322 | 1 + 0 | 16 | 32 | 1a1a | 197 |
571 | 0 + 0 | 17 | 8 | 1a1a | 323 |
481 | 2 + 1 | 18 | 16 | 1a1b | 192 |
431 | 0 + 0 | 37 | 2 | 1a1b | 491 |
607 | 0 + 0 | 37 | 4 | ND | 228 |
Transient Antenatal Antibodies (n = 6) | |||||
487 | 3 + 1 | 8 | 2 | 1a1b | ND |
614 | 1 + 0 | 8 | 2 | 1a1b | 267 |
605 | 1 + 0 | 9 | 1 | ND | 133 |
398 | 3 + 0 | 15 | 1 | ND | 261 |
206 | 2 + 1 | 16 | 1 | ND | 604 |
420 | 0 + 1 | 20 | 1 | ND | 352 |
Postnatal Antibodies Only With HPA-1a–Positive Baby¶ (n = 7) | |||||
42-151 | 0 + 0 | PN | 1 | 1a1a | ND |
62 | 2 + 1 | PN | 8 | ND | 275 |
221 | 0 + 1 | PN | 2 | 1a1a | 153 |
267 | 1 + 0 | PN | 4 | 1a1b | 274 |
302 | 1 + 3 | PN | 4 | 1a1a | SA 15/40 |
325 | 0 + 0 | PN | 1 | ND | 146 |
412 | 1 + 2 | PN | 4 | 1a1a | 53 |
Antenatal Antibodies With HPA-1a–Negative Baby (n = 6) | |||||
417 | 1 + 1 | 11 | 32 | 1a1b | 286 |
199# | 0 + 1 | 17 | 4 | 1a1b | 222 |
230-160 | 1 + 2 | 17 | 16 | 1b1b | 229 |
304 | 4 + 0 | 26 | 2 | 1a1b | 384 |
172 | 2 + 0 | 29 | 1 | 1a1b | 341 |
542 | 0 + 1 | 35 | 2 | ND | 285 |
Within each category, cases are listed according to timing of first detectable antibody.
Abbreviations: ND, not determined; SA, spontaneous abortion; PN, postnatal.
Parity: number of births after 24 weeks + number before 24 weeks.
Also produced anti–HPA-5b antenatally.
Two pregnancies during the study period.
Intracerebral hemorrhage in utero.
Not originally typed as HPA-1a negative.
¶Titre refers to postnatal sample.
#HLA-DRB3 *0101 negative.
New partner: previous child HPA-1a positive with severe thrombocytopenia.